These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 39178138

  • 1. Atrial tachyarrhythmia prevention by Shensong Yangxin after catheter ablation for persistent atrial fibrillation: the SS-AFRF trial.
    Huang H, Liu Y, Shuai W, Jiang C, Zhang M, Qu X, Zheng W, Yang H, Liu F, Yu B, Chen M, Mu B, Yao C, Tang Y, Huang C, Ouyang F, Jia Z.
    Eur Heart J; 2024 Oct 21; 45(40):4305-4314. PubMed ID: 39178138
    [Abstract] [Full Text] [Related]

  • 2. Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial).
    Darkner S, Chen X, Hansen J, Pehrson S, Johannessen A, Nielsen JB, Svendsen JH.
    Eur Heart J; 2014 Dec 14; 35(47):3356-64. PubMed ID: 25182250
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Shensong Yangxin capsule combined with dronedarone in paroxysmal atrial fibrillation after ablation.
    Zhou T, Gong P, Xu M, Yan L, Zhang Y.
    Medicine (Baltimore); 2024 Apr 26; 103(17):e37918. PubMed ID: 38669399
    [Abstract] [Full Text] [Related]

  • 4. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial.
    Zhang XD, Gu J, Jiang WF, Zhao L, Zhou L, Wang YL, Liu YG, Liu X.
    Eur Heart J; 2014 May 21; 35(20):1327-34. PubMed ID: 24497338
    [Abstract] [Full Text] [Related]

  • 5. The Different Therapeutic Effects of Traditional Chinese Medicine Shensong Yangxin Capsule and Salubrinal in High-intensity Exercise-induced Heart Failure in Rats with Acute Myocardial Infarction.
    Lu J, Ma Y, Lv H, Li C, Ru L, Zhao J, Wang D.
    Comb Chem High Throughput Screen; 2024 May 21; 27(11):1592-1601. PubMed ID: 38305401
    [Abstract] [Full Text] [Related]

  • 6. Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.
    Poole JE, Bahnson TD, Monahan KH, Johnson G, Rostami H, Silverstein AP, Al-Khalidi HR, Rosenberg Y, Mark DB, Lee KL, Packer DL, CABANA Investigators and ECG Rhythm Core Lab.
    J Am Coll Cardiol; 2020 Jun 30; 75(25):3105-3118. PubMed ID: 32586583
    [Abstract] [Full Text] [Related]

  • 7. PulmOnary vein isolation With vs. without continued antiarrhythmic Drug trEatment in subjects with Recurrent Atrial Fibrillation (POWDER AF): results from a multicentre randomized trial.
    Duytschaever M, Demolder A, Phlips T, Sarkozy A, El Haddad M, Taghji P, Knecht S, Tavernier R, Vandekerckhove Y, De Potter T.
    Eur Heart J; 2018 Apr 21; 39(16):1429-1437. PubMed ID: 29211857
    [Abstract] [Full Text] [Related]

  • 8. Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure.
    Ma J, Yin C, Ma S, Qiu H, Zheng C, Chen Q, Ding C, Lv W.
    Drug Des Devel Ther; 2018 Apr 21; 12():3407-3418. PubMed ID: 30349194
    [Abstract] [Full Text] [Related]

  • 9. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study).
    Mont L, Bisbal F, Hernández-Madrid A, Pérez-Castellano N, Viñolas X, Arenal A, Arribas F, Fernández-Lozano I, Bodegas A, Cobos A, Matía R, Pérez-Villacastín J, Guerra JM, Ávila P, López-Gil M, Castro V, Arana JI, Brugada J, SARA investigators.
    Eur Heart J; 2014 Feb 21; 35(8):501-7. PubMed ID: 24135832
    [Abstract] [Full Text] [Related]

  • 10. Effect of Shensong Yangxin on the Progression of Paroxysmal Atrial Fibrillation is Correlated with Regulation of Autonomic Nerve Activity.
    Zhao HY, Zhang SD, Zhang K, Wang X, Zhao QY, Zhang SJ, Dai ZX, Qian YS, Zhang YJ, Wei HT, Tang YH, Huang CX.
    Chin Med J (Engl); 2017 Jan 20; 130(2):171-178. PubMed ID: 28091409
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of Antiarrhythmic Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation (EAST-AF) trial.
    Kaitani K, Inoue K, Kobori A, Nakazawa Y, Ozawa T, Kurotobi T, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Kawaji T, Yoshizawa T, Toyota T, Yahata M, Nakai K, Sugiyama H, Higashi Y, Ito M, Horie M, Kusano KF, Shimizu W, Kamakura S, Morimoto T, Kimura T, Shizuta S, EAST-AF Trial Investigators.
    Eur Heart J; 2016 Feb 14; 37(7):610-8. PubMed ID: 26417061
    [Abstract] [Full Text] [Related]

  • 12. Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial.
    Suleiman M, Koestler C, Lerman A, Lopez-Jimenez F, Herges R, Hodge D, Bradley D, Cha YM, Brady PA, Munger TM, Asirvatham SJ, Packer DL, Friedman PA.
    Heart Rhythm; 2012 Feb 14; 9(2):172-8. PubMed ID: 21920481
    [Abstract] [Full Text] [Related]

  • 13. Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry.
    Boersma L, Koźluk E, Maglia G, de Sousa J, Grebe O, Eckardt L, Hokanson RB, Hemingway LA, Ostern E, Park HS, Rovaris G, Arribas F, Scharf C, Csanádi Z, Arenal Á, Laurenzi F, Klaver M, Goette A.
    Europace; 2020 Jun 01; 22(6):888-896. PubMed ID: 32219388
    [Abstract] [Full Text] [Related]

  • 14. Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial.
    Marrouche NF, Wazni O, McGann C, Greene T, Dean JM, Dagher L, Kholmovski E, Mansour M, Marchlinski F, Wilber D, Hindricks G, Mahnkopf C, Wells D, Jais P, Sanders P, Brachmann J, Bax JJ, Morrison-de Boer L, Deneke T, Calkins H, Sohns C, Akoum N, DECAAF II Investigators.
    JAMA; 2022 Jun 21; 327(23):2296-2305. PubMed ID: 35727277
    [Abstract] [Full Text] [Related]

  • 15. Shensong Yangxin attenuates metabolic syndrome-induced atrial fibrillation via inhibition of ferroportin-mediated intracellular iron overload.
    Yang HJ, Kong B, Shuai W, Zhang JJ, Huang H.
    Phytomedicine; 2022 Jul 21; 101():154086. PubMed ID: 35421806
    [Abstract] [Full Text] [Related]

  • 16. Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) trial.
    Kobori A, Shizuta S, Inoue K, Kaitani K, Morimoto T, Nakazawa Y, Ozawa T, Kurotobi T, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Kawaji T, Yoshizawa T, Toyota T, Yahata M, Nakai K, Sugiyama H, Higashi Y, Ito M, Horie M, Kusano KF, Shimizu W, Kamakura S, Kimura T, UNDER-ATP Trial Investigators.
    Eur Heart J; 2015 Dec 07; 36(46):3276-87. PubMed ID: 26321237
    [Abstract] [Full Text] [Related]

  • 17. Twelve-year follow-up of catheter ablation for atrial fibrillation: A prospective, multicenter, randomized study.
    Bertaglia E, Senatore G, De Michieli L, De Simone A, Amellone C, Ferretto S, La Rocca V, Giuggia M, Corrado D, Zoppo F, Stabile G.
    Heart Rhythm; 2017 Apr 07; 14(4):486-492. PubMed ID: 27989681
    [Abstract] [Full Text] [Related]

  • 18. Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial.
    Valderrábano M, Peterson LE, Swarup V, Schurmann PA, Makkar A, Doshi RN, DeLurgio D, Athill CA, Ellenbogen KA, Natale A, Koneru J, Dave AS, Giorgberidze I, Afshar H, Guthrie ML, Bunge R, Morillo CA, Kleiman NS.
    JAMA; 2020 Oct 27; 324(16):1620-1628. PubMed ID: 33107945
    [Abstract] [Full Text] [Related]

  • 19. Cryoballoon vs. radiofrequency catheter ablation: insights from NOrwegian randomized study of PERSistent Atrial Fibrillation (NO-PERSAF study).
    Shi LB, Rossvoll O, Tande P, Schuster P, Solheim E, Chen J.
    Europace; 2022 Feb 02; 24(2):226-233. PubMed ID: 35134151
    [Abstract] [Full Text] [Related]

  • 20. Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial.
    Kistler PM, Chieng D, Sugumar H, Ling LH, Segan L, Azzopardi S, Al-Kaisey A, Parameswaran R, Anderson RD, Hawson J, Prabhu S, Voskoboinik A, Wong G, Morton JB, Pathik B, McLellan AJ, Lee G, Wong M, Finch S, Pathak RK, Raja DC, Sterns L, Ginks M, Reid CM, Sanders P, Kalman JM.
    JAMA; 2023 Jan 10; 329(2):127-135. PubMed ID: 36625809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.